{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alveolar bone", "Osteoblast", "Osteoclast", "Periodontitis", "Zanthoxylum piperitum"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27777167", "DateCompleted": {"Year": "2017", "Month": "07", "Day": "03"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "10", "Day": "21"}], "ELocationID": ["10.1016/j.jep.2016.10.057", "S0378-8741(16)31436-2"], "Language": ["eng"], "Journal": {"ISSN": "1872-7573", "JournalIssue": {"Volume": "195", "PubDate": {"Year": "2017", "Month": "Jan", "Day": "04"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Zanthoxylum piperitum reversed alveolar bone loss of periodontitis via regulation of bone remodeling-related factors.", "Pagination": {"StartPage": "137", "EndPage": "142", "MedlinePgn": "137-142"}, "Abstract": {"AbstractText": ["Zanthoxylum piperitum (ZP) has been used to prevent toothache in East Asia.", "In this study, we investigated the effects of ZP on periodontitis along with alveolar bone loss.", "Twenty-eight male Sprague-Dawley rats were assigned into 4 groups; non-ligated (NOR), ligated and treated vehicle (CTR), ligated and treated 1mg/mL ZP (ZP1), and ligated and treated 100mg/mL ZP (ZP100). Sterilized 3-0 nylon ligature was placed into the subgingival sulcus around the both sides of mandibular first molar. After topical application of 1 and 100mg/mL ZP for 2 weeks, mandibles was removed for histology. In addition, SaOS-2 osteoblast cells were treated 1, 10 and 100\u03bcg/mL ZP for 24h to analyze the expressions of alveolar bone-related markers.", "Several alveolar bone resorption pits, which indicate cementum demineralization were decreased by ZP treatment. Topical ZP treatment inhibited periodontitis-induced alveolar bone loss. In addition, there were significant reduction of osteoclastic activities following topical ZP treatment in periodontium. The expression of RANKL was decreased in SaOS-2 osteoblast cells by treating ZP, while that of OPG was increased. ZP treatment increased the expressions of Runx2 and Osterix in SaOS-2 cells.", "In summary, ZP treatment inhibited alveolar bone loss as well as maintained the integrity of periodontal structures via regulation of bone remodeling. ZP may be a therapeutic target for treating periodontitis."], "CopyrightInformation": "Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Convergence Korean Medical Science, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea."}], "LastName": "Kim", "ForeName": "Mi Hye", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Convergence Korean Medical Science, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea."}], "LastName": "Lee", "ForeName": "Hye Ji", "Initials": "HJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Periodontology, College of Dentistry, Dankook University, Cheonan, Republic of Korea."}], "LastName": "Park", "ForeName": "Jung-Chul", "Initials": "JC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea."}], "LastName": "Hong", "ForeName": "Jongki", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Convergence Korean Medical Science, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea. Electronic address: wmyang@khu.ac.kr."}], "LastName": "Yang", "ForeName": "Woong Mo", "Initials": "WM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Bone Density Conservation Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Core Binding Factor Alpha 1 Subunit"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "RANK Ligand"}, {"RegistryNumber": "0", "NameOfSubstance": "RUNX2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Sp7 Transcription Factor"}, {"RegistryNumber": "0", "NameOfSubstance": "SP7 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "TNFSF11 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factors"}], "MeshHeadingList": [{"QualifierName": ["metabolism", "physiopathology", "prevention & control"], "DescriptorName": "Alveolar Bone Loss"}, {"QualifierName": ["drug effects", "metabolism", "physiopathology"], "DescriptorName": "Alveolar Process"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Biomarkers"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Bone Density Conservation Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Bone Remodeling"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["metabolism"], "DescriptorName": "Core Binding Factor Alpha 1 Subunit"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Osteoblasts"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Osteoclasts"}, {"QualifierName": ["drug therapy", "metabolism", "physiopathology"], "DescriptorName": "Periodontitis"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism"], "DescriptorName": "RANK Ligand"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "Sp7 Transcription Factor"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Transcription Factors"}, {"QualifierName": ["chemistry"], "DescriptorName": "Zanthoxylum"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "2", "Day": "24"}, {"Year": "2016", "Month": "9", "Day": "23"}, {"Year": "2016", "Month": "10", "Day": "19"}, {"Year": "2016", "Month": "10", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "10", "Day": "26", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27777167", "10.1016/j.jep.2016.10.057", "S0378-8741(16)31436-2"]}}], "PubmedBookArticle": []}